ZA93234B - Flavour-masked pharmaceutical compositions - Google Patents

Flavour-masked pharmaceutical compositions

Info

Publication number
ZA93234B
ZA93234B ZA93234A ZA93234A ZA93234B ZA 93234 B ZA93234 B ZA 93234B ZA 93234 A ZA93234 A ZA 93234A ZA 93234 A ZA93234 A ZA 93234A ZA 93234 B ZA93234 B ZA 93234B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
flavour
masked pharmaceutical
taste
masked
Prior art date
Application number
ZA93234A
Other languages
English (en)
Inventor
Norbert Poellinger
Johannes Michaelis
Klaus Benke
Roland Rupp
Manfred Buecheler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6449525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA93234(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA93234B publication Critical patent/ZA93234B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA93234A 1992-01-15 1993-01-14 Flavour-masked pharmaceutical compositions ZA93234B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4200821A DE4200821A1 (de) 1992-01-15 1992-01-15 Geschmacksmaskierte pharmazeutische mittel

Publications (1)

Publication Number Publication Date
ZA93234B true ZA93234B (en) 1993-08-16

Family

ID=6449525

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93234A ZA93234B (en) 1992-01-15 1993-01-14 Flavour-masked pharmaceutical compositions

Country Status (24)

Country Link
US (2) US5695784A (zh)
EP (1) EP0551820B1 (zh)
JP (1) JP3734279B2 (zh)
KR (1) KR100288523B1 (zh)
CN (1) CN1052399C (zh)
AT (1) ATE186212T1 (zh)
AU (1) AU670763B2 (zh)
CA (1) CA2087146C (zh)
CZ (1) CZ283787B6 (zh)
DE (2) DE4200821A1 (zh)
DK (1) DK0551820T3 (zh)
ES (1) ES2141117T3 (zh)
GR (1) GR3032382T3 (zh)
HK (1) HK1005987A1 (zh)
HU (2) HU219592B (zh)
IL (1) IL104362A (zh)
MX (1) MX9207630A (zh)
MY (1) MY111177A (zh)
NZ (1) NZ245658A (zh)
PL (1) PL175569B1 (zh)
RU (1) RU2110255C1 (zh)
SK (1) SK280999B6 (zh)
TW (1) TW366286B (zh)
ZA (1) ZA93234B (zh)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
FI111796B (fi) * 1997-05-28 2003-09-30 Finnfeeds Finland Oy Kiinteä betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö
DE19809719A1 (de) * 1998-03-06 1999-09-09 Roehm Gmbh Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
US5976507A (en) * 1998-06-04 1999-11-02 Colgate Palmolive Company Dentrifice composition containing encapsulated reactive ingredients
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6270807B1 (en) * 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
GB9911546D0 (en) * 1999-05-19 1999-07-21 Core Technologies Limited Release of poorly soluble agents
DE19930557B4 (de) * 1999-07-02 2005-12-08 Bayer Healthcare Ag Verfahren zur Herstellung von Hydraten von Ciprofloxacin und von Ciprofloxacin-Anhydrat enthaltenden pharmazeutischen Zusammensetzungen
KR20020029668A (ko) 1999-07-09 2002-04-19 다우 케네드 제이. 풍미 차단된 약제학적 액상 제제
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
DE60005469T3 (de) * 1999-12-22 2007-08-09 Dsm Ip Assets B.V. Arzneizusammensetzung enthaltend Ascorbinsäure und Pektin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2002043694A2 (en) 2000-11-28 2002-06-06 Fmc Corporation Edible pga(propylene glycol alginate) coating composition
US20020122824A1 (en) * 2001-01-24 2002-09-05 Francisco Cabrera Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
US6767557B2 (en) 2001-03-05 2004-07-27 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
CA2448927C (en) * 2001-05-30 2011-08-09 Euro-Celtique, S.A. Pharmaceutical composition
KR100628603B1 (ko) * 2001-09-03 2006-09-26 디에스엠 아이피 어셋츠 비.브이. 펙틴 및 아스코르브산을 포함하는 조성물
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
AU2003220551A1 (en) * 2002-03-26 2003-10-13 Euro-Celtique S.A. Sustained-release gel coated compositions
CA2480826C (fr) * 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
US20030198892A1 (en) * 2002-04-22 2003-10-23 General Electric Company Limited play data storage media and method for limiting access to data thereon
US20030205323A1 (en) * 2002-04-22 2003-11-06 General Electric Company Method for making limited play data storage media
AU2003249904A1 (en) * 2002-07-02 2004-01-23 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20050269722A1 (en) * 2002-07-17 2005-12-08 Stefano De Luigi Brushci Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
KR20040011087A (ko) * 2002-07-27 2004-02-05 주식회사 씨티씨바이오 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법
US20040087692A1 (en) * 2002-10-30 2004-05-06 Dixit Arun Nandkishor Method for preparation of an anthraquinone colorant composition
EP1581197A1 (en) * 2002-12-11 2005-10-05 Ranbaxy Laboratories, Limited Coating composition for taste masking coating and methods for their application and use
US20040146553A1 (en) * 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
SI1594500T1 (sl) * 2003-02-10 2011-02-28 Bayer Schering Pharma Ag Zdravljenje bakterijskih bolezni dihalnih organov z lokalno aplikacijo fluorokinolonov
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
US7087282B2 (en) * 2003-07-15 2006-08-08 General Electric Company Limited play optical storage medium, method for making the same
US7202292B2 (en) * 2003-07-15 2007-04-10 General Electric Company Colored polymeric resin composition with 1,8-diaminoanthraquinone derivative, article made therefrom, and method for making the same
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
JP2005343800A (ja) * 2004-05-31 2005-12-15 Lion Corp 被覆カフェイン粒子、固形製剤および眠気防止薬
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
ATE428416T1 (de) * 2005-06-21 2009-05-15 Merck Patent Gmbh Feste pharmazeutische zubereitung enthaltend (r)- (-)-2-ä5-(4-fluorophenyl)-3- pyridylmethylaminomethylü-chroman
US20080213441A1 (en) * 2006-12-27 2008-09-04 Cathy Jean Ludwig Reduction of Astringency in Polyphenol Compositions
BRPI0701693A2 (pt) * 2007-05-10 2008-12-23 Inst Pesquisas Sao Paulo processo de encapsulaÇço de substÂncias quÍmicamente ativas e produto encapsulado resultante
KR100867639B1 (ko) 2007-06-08 2008-11-10 (주)다산메디켐 고미가 차폐된 염산 도네페질-함유 입자, 이를 포함하는약학 조성물, 및 이들의 제조방법
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
DE102008035542A1 (de) 2008-07-30 2010-02-04 Siemens Aktiengesellschaft Verfahren zur Ermittlung von Messdaten aus dem Magen eines Patienten
EP2376514A2 (en) * 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
NZ593648A (en) * 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
KR20140069381A (ko) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 서방출 투여형
ES2668203T3 (es) * 2009-12-02 2018-05-17 Adare Pharmaceuticals S.R.L. Microcápsulas de fexofenadina y composiciones que las contienen
US20110236494A1 (en) * 2010-03-04 2011-09-29 Ranbaxy Laboratories Limited Ciprofloxacin oral suspension
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
EP2552933A1 (en) 2010-03-31 2013-02-06 Gilead Pharmasset LLC Purine nucleoside phosphoramidate
PT2558079T (pt) * 2010-04-12 2019-09-05 S Zhaveri Pharmakem Pvt Ltd Composição de xarope seco de ciprofloxacina
CN101985044B (zh) * 2010-07-16 2013-10-23 钟术光 一种掩味的药物涂层组合物
US8841275B2 (en) 2010-11-30 2014-09-23 Gilead Pharmasset Llc 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
JP2014521713A (ja) 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 味をマスキングした医薬組成物
ES2761265T3 (es) 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación de oxcarbazepina rápidamente dispersable
WO2014144661A1 (en) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
RU2599007C1 (ru) * 2015-08-24 2016-10-10 Александр Александрович Кролевец Способ получения нанокапсул ципрофлоксацина гидрохлорида в альгинате натрия
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
CN105343028B (zh) * 2015-11-25 2018-08-21 万邦德制药集团股份有限公司 一种诺氟沙星的药物组合物及其制备方法
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN116459222A (zh) * 2023-04-20 2023-07-21 山东中医药大学附属医院 一种匹维溴铵组合物、制剂及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
DE3808277A1 (de) * 1988-03-12 1989-09-21 Bayer Ag Verfahren und vorrichtung zur wirbelschichtspruehgranulation
EP0163836B1 (de) * 1984-04-07 1988-10-12 Bayer Ag Verfahren und Vorrichtung zur Herstellung von Granulaten
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
DE3685573T2 (de) * 1986-01-24 1993-02-04 Valeo Electronique Zuendspule mit geschlossenem magnetischem kreis.
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
GB8723896D0 (en) * 1987-10-12 1987-11-18 Aps Research Ltd Controlled-release formulation
DE3808116A1 (de) * 1988-03-11 1989-09-21 Bayer Ag Zick-zack-sichter
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
DE3920082A1 (de) * 1989-06-20 1991-03-07 Roehm Gmbh Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel

Also Published As

Publication number Publication date
HU219592B (hu) 2001-05-28
IL104362A (en) 1997-04-15
SK372092A3 (en) 1995-05-10
PL175569B1 (pl) 1999-01-29
KR100288523B1 (ko) 2001-09-17
CN1052399C (zh) 2000-05-17
HUT64693A (en) 1994-02-28
ATE186212T1 (de) 1999-11-15
TW366286B (en) 1999-08-11
AU670763B2 (en) 1996-08-01
HU211154A9 (en) 1995-10-30
ES2141117T3 (es) 2000-03-16
MY111177A (en) 1999-09-30
JP3734279B2 (ja) 2006-01-11
CA2087146A1 (en) 1993-07-16
MX9207630A (es) 1993-07-30
RU2110255C1 (ru) 1998-05-10
CZ372092A3 (en) 1993-08-11
CA2087146C (en) 2003-03-18
EP0551820B1 (de) 1999-11-03
JPH05255072A (ja) 1993-10-05
NZ245658A (en) 1995-02-24
DK0551820T3 (da) 2000-04-25
HU9300085D0 (en) 1993-04-28
SK280999B6 (sk) 2000-10-09
AU3113893A (en) 1993-07-22
CZ283787B6 (cs) 1998-06-17
IL104362A0 (en) 1993-05-13
GR3032382T3 (en) 2000-04-27
US5695784A (en) 1997-12-09
DE59309858D1 (de) 1999-12-09
US6136347A (en) 2000-10-24
HK1005987A1 (en) 1999-02-05
DE4200821A1 (de) 1993-07-22
EP0551820A1 (de) 1993-07-21
CN1074603A (zh) 1993-07-28
PL297399A1 (en) 1993-08-09

Similar Documents

Publication Publication Date Title
GR3032382T3 (en) Taste-masked pharmaceutical compositions.
DE19975040I2 (de) Medikamente enthaltend Salmeterol und Fluticason
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
BRPI0013439A (pt) composição compreendendo tramadol e um fármaco anticonvulsivante.
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
ES2180629T3 (es) Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad.
DK0416950T3 (da) Medikamenter
FR2682040B1 (fr) Medicaments pour traiter les troubles gastrointestinaux.
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
DE59206864D1 (de) Arzneimittel enthaltend Protein C
HU9400685D0 (en) Veterinary composition of anesthetic activity
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
FR2521010B1 (fr) Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
IT1251993B (it) Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico